Cargando…
The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial
BACKGROUND: Antipsychotic drugs are an important part of the treatment of irritability and aggression in children with an autism spectrum disorder (ASD). However, significant weight gain and metabolic disturbances are clinically relevant side effects of antipsychotic use in children. In the SPACe st...
Autores principales: | Hermans, Rebecca A., Ringeling, Lisa T., Liang, Kajie, Kloosterboer, Sanne M., de Winter, Brenda C. M., Hillegers, Manon H. J., Koch, Birgit C. P., Dierckx, Bram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769061/ https://www.ncbi.nlm.nih.gov/pubmed/36539734 http://dx.doi.org/10.1186/s12888-022-04445-6 |
Ejemplares similares
-
Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder
por: Kloosterboer, Sanne Maartje, et al.
Publicado: (2020) -
Assessing methods of measuring medication adherence in chronically ill children–a narrative review
por: Al-Hassany, Linda, et al.
Publicado: (2019) -
Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar, Fatemeh, et al.
Publicado: (2015) -
Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015) -
Risk factors and pattern of weight gain in youths using antipsychotic drugs
por: van der Esch, Casper C. L., et al.
Publicado: (2020)